Steclo PG Tablets

Steclo PG — Dual-Action Sustained-Release Pain Relief

Neuropathic Pain • Joint Pain • SR Formulation

Steclo PG Tablets combine Aceclofenac SR 200 mg and Pregabalin SR 75 mg to provide extended pain relief for both inflammatory joint conditions and neuropathic pain disorders. The sustained-release design ensures long-lasting therapeutic effects with improved patient compliance.

Key Ingredients

  • Aceclofenac SR 200 mg — A non-steroidal anti-inflammatory drug (NSAID) that reduces pain, inflammation, and stiffness by inhibiting prostaglandin synthesis.
  • Pregabalin SR 75 mg — A neuropathic pain modulator that works on calcium channels to decrease abnormal nerve signaling.

Key Benefits

  • Effective Pain Management — Provides relief in osteoarthritis, rheumatoid arthritis, joint inflammation, and other musculoskeletal conditions.
  • Anti-Inflammatory Relief — Aceclofenac reduces swelling, stiffness, and joint discomfort, improving movement and daily function.
  • Neuropathic Pain Control — Pregabalin helps manage nerve-related pain such as diabetic neuropathy, fibromyalgia, and post-herpetic neuralgia.
  • Sustained-Release Advantage — Longer-lasting relief with reduced dosing frequency, enhancing treatment adherence.

Storage

Store Steclo PG Tablets in a cool, dry place away from direct heat, sunlight, and moisture. Keep out of reach of children.

Steclo PG Tablets deliver a powerful dual approach by combining anti-inflammatory and neuropathic pain relief in one sustained-release formulation. It is an effective solution for chronic pain conditions when used under proper medical guidance.
Aster MediPharm offers high-value business growth through its PCD pharma franchise, providing strong product support, marketing resources, and a reputable portfolio. Start your franchise journey with us today for long-term success in the pharmaceutical sector.
OUR DIVISION
contact us on WhatsApp